"Demyelinating Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Diseases characterized by loss or dysfunction of myelin in the central or peripheral nervous system.
Below are MeSH descriptors whose meaning is more general than "Demyelinating Diseases".
Below are MeSH descriptors whose meaning is more specific than "Demyelinating Diseases".
This graph shows the total number of publications written about "Demyelinating Diseases" by people in this website by year, and whether "Demyelinating Diseases" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Demyelinating Diseases" by people in Profiles.
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Presentation, Diagnosis, and Management. Pediatr Ann. 2021 Jun; 50(6):e254-e258.
Development of a PET radioligand for potassium channels to image CNS demyelination. Sci Rep. 2018 01 12; 8(1):607.
Detecting Demyelination by PET: The Lesion as Imaging Target. Mol Imaging. 2018 Jan-Dec; 17:1536012118785471.
Automated Radiochemical Synthesis of [18F]3F4AP: A Novel PET Tracer for Imaging Demyelinating Diseases. J Vis Exp. 2017 05 29; (123).
Endoplasmic reticulum stress and the unfolded protein response in disorders of myelinating glia. Brain Res. 2016 10 01; 1648(Pt B):594-602.
Loss of Allograft Inflammatory Factor-1 Ameliorates Experimental Autoimmune Encephalomyelitis by Limiting Encephalitogenic CD4 T-Cell Expansion. Mol Med. 2015 Jan 06; 21:233-41.
Genetic inactivation of PERK signaling in mouse oligodendrocytes: normal developmental myelination with increased susceptibility to inflammatory demyelination. Glia. 2014 May; 62(5):680-91.
Youth and environmental enrichment generate serum exosomes containing miR-219 that promote CNS myelination. Glia. 2014 Feb; 62(2):284-99.
IFN?-stimulated dendritic cell exosomes as a potential therapeutic for remyelination. J Neuroimmunol. 2014 Jan 15; 266(1-2):12-23.
CNS demyelination in fibrodysplasia ossificans progressiva. J Neurol. 2012 Dec; 259(12):2644-55.